Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lung Neoplasms × Docosahexaenoic Acids × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Infections 1

Interventions

Cisplatin 39 Carboplatin 26 Gemcitabine 22 Docetaxel 20 Radiotherapy 17 Etoposide 16 Erlotinib Hydrochloride 13 Paclitaxel 12 Drug Therapy 11 Vinorelbine 10 apatinib 8 Gefitinib 8 Blood Specimen Collection 8 endostar protein 7 aumolertinib 7 Thoracic Surgery, Video-Assisted 7 pembrolizumab 6 Vinblastine 6 Pemetrexed 6 sintilimab 5 osimertinib 5 durvalumab 5 anlotinib 5 Surgical Procedures, Operative 5 Fluorodeoxyglucose F18 5 Cyclophosphamide 5 camrelizumab 4 Mitomycin 4 Ifosfamide 4 Hematologic Tests 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03936621 2019-05-07

Omega

British Columbia Cancer Agency

Phase 2 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡